The Ratio of Eicosapentaenoic Acid (EPA) to Arachidonic Acid may be a Residual Risk Marker in Stable Coronary Artery Disease Patients Receiving Treatment with Statin Following EPA Therapy
Sign Up to like & getrecommendations! Published in 2017 at "American Journal of Cardiovascular Drugs"
DOI: 10.1007/s40256-017-0238-z
Abstract: BackgroundWe investigated the relationship between the eicosapentaenoic acid (EPA)/arachidonic acid (AA) ratio and non-high-density lipoprotein cholesterol (non-HDL-C) level, a major residual risk of coronary artery disease (CAD), in statin-treated CAD patients following EPA therapy.MethodsWe conducted… read more here.
Keywords: non hdl; ratio; epa; residual risk ... See more keywords
Residual risk for clinically significant copy number variants in low-risk pregnancies, following exclusion of NIPS-detectable findings.
Sign Up to like & getrecommendations! Published in 2021 at "American journal of obstetrics and gynecology"
DOI: 10.1016/j.ajog.2021.11.016
Abstract: BACKGROUND Chromosomal microarray analysis (CMA) detects clinically significant copy number variants (CNVs) in about 1% of low-risk pregnancies. As the constantly growing wide use of non-invasive prenatal screening (NIPS) facilitates the detection of chromosomal aberrations,… read more here.
Keywords: risk; risk clinically; clinically significant; nips detectable ... See more keywords
On the optimality of linear residual risk sharing
Sign Up to like & getrecommendations! Published in 2025 at "ASTIN Bulletin"
DOI: 10.1017/asb.2024.37
Abstract: Abstract In this paper, we explore the optimal risk sharing problem in the context of peer-to-peer insurance. Using the criterion of minimizing total variance, we find that the optimal risk sharing strategy should take a… read more here.
Keywords: risk sharing; variance; linear residual; risk ... See more keywords
Targeting PCSK9 to reduce residual risk in ACS
Sign Up to like & getrecommendations! Published in 2018 at "Nature Reviews Cardiology"
DOI: 10.1038/s41569-018-0125-6
Abstract: Patients who have had an acute coronary syndrome (ACS) are at high risk of recurrent cardiovascular events, particularly patients whose LDLcholesterol (LDLC) levels remain elevated despite receiving highintensity statin therapy. The ODYSSEY OUTCOMES trial now… read more here.
Keywords: risk; pcsk9 reduce; targeting pcsk9; pcsk9 ... See more keywords
Recently Acquired Blood-borne Virus Infections in Australian Deceased Organ Donors: Estimation of the Residual Risk of Unexpected Transmission
Sign Up to like & getrecommendations! Published in 2023 at "Transplantation Direct"
DOI: 10.1097/txd.0000000000001447
Abstract: Background: Unexpected donor-derived infections of hepatitis B virus (HBV), hepatitis C virus (HCV), and HIV are rare but important potential complications of deceased organ transplantation. The prevalence of recently acquired (yield) infections has not been… read more here.
Keywords: recently acquired; deceased organ; risk; yield ... See more keywords
The Impact of Critical Care Quarantine on the Residual Risk of Unexpected Organ Donor Blood-borne Virus Infection
Sign Up to like & getrecommendations! Published in 2025 at "Transplantation Direct"
DOI: 10.1097/txd.0000000000001843
Abstract: Background. The transmission of undetected infections from organ donors to recipients is a persistent concern in transplantation medicine. Despite nucleic acid testing, some infections, especially those acquired recently, may evade detection. This study aimed to… read more here.
Keywords: risk; virus; blood; residual risk ... See more keywords
Residual risk estimates of transfusion transmissible hepatitis B, hepatitis C and human immunodeficiency virus using nucleic acid testing yield/window period model in an Indian setting
Sign Up to like & getrecommendations! Published in 2022 at "Transfusion Medicine"
DOI: 10.1111/tme.12923
Abstract: Estimation of residual risk (RR) is necessary to understand status of blood safety with current testing strategies and need to improve it further. These estimates from India are lacking till date. Present study was aimed… read more here.
Keywords: estimates transfusion; risk estimates; hepatitis; residual risk ... See more keywords
Do high‐risk behavior deferrals work? How to make it better?
Sign Up to like & getrecommendations! Published in 2019 at "Transfusion"
DOI: 10.1111/trf.15409
Abstract: H igh-risk behavior deferrals are one of several mechanisms employed by blood centers to reduce transfusion-transmitted infection (TTI) risk. Predonation donor screening includes a donor history questionnaire (DHQ) interview before eligible donors undergo TTI screening… read more here.
Keywords: risk; high risk; donor; risk behavior ... See more keywords
Prevalence, incidence, and residual risk for human immunodeficiency virus among blood donors from 2003 to 2022 in Guangzhou, China
Sign Up to like & getrecommendations! Published in 2024 at "Transfusion"
DOI: 10.1111/trf.18025
Abstract: China's significant population affected by HIV poses a substantial threat to blood transfusion safety. Despite advancements in blood testing techniques, a residual risk of HIV transmission persists. Accurately assessing HIV epidemic and the residual risk… read more here.
Keywords: prevalence incidence; blood; china; residual risk ... See more keywords
Residual recurrence risk of ischaemic cerebrovascular events: concept, classification and implications
Sign Up to like & getrecommendations! Published in 2021 at "Stroke and Vascular Neurology"
DOI: 10.1136/svn-2021-000885
Abstract: © Author(s) (or their employer(s)) 2021. Reuse permitted under CC BYNC. No commercial reuse. See rights and permissions. Published by BMJ. INTRODUCTION Patients with stroke still have substantial residual risk of stroke recurrence in spite… read more here.
Keywords: risk; recurrence risk; recurrence; stroke recurrence ... See more keywords
Revisiting Cardiovascular Benefits of Blood Pressure Reduction in Primary and Secondary Prevention: Focus on Targets and Residual Risk—A Systematic Review and Meta-Analysis
Sign Up to like & getrecommendations! Published in 2024 at "Hypertension"
DOI: 10.1161/hypertensionaha.123.22610
Abstract: BACKGROUND: Previous meta-analyses resurrected the debated statement “the lower, the better” following blood pressure (BP)-lowering treatment. We investigated the benefits of BP-lowering treatment at different BP targets by prevention category. METHODS: The meta-analysis protocol was… read more here.
Keywords: meta analysis; risk; primary secondary; prevention ... See more keywords